New way found to treat early relapse in leukemia
Researchers at Peter Mac have found a new way to treat a form of leukemia that stops the disease in its tracks to prolong remission.
Apr 15, 2024
0
1
Researchers at Peter Mac have found a new way to treat a form of leukemia that stops the disease in its tracks to prolong remission.
Apr 15, 2024
0
1
More than 22% of older hospitalized adults with respiratory syncytial virus (RSV) infection experience an acute cardiac event, according to a study published online April 15 in JAMA Internal Medicine.
Apr 15, 2024
0
0
An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular ...
Apr 15, 2024
0
0
Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and remained ...
Apr 13, 2024
0
10
Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection. Now, a new, commercially viable method of treatment is ...
Apr 13, 2024
0
1
A new research paper titled "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia" has been published in Oncotarget.
Apr 10, 2024
0
0
Bedsores—also known as pressure injuries—are the fastest rising hospital-acquired condition, according to the U.S. Agency for Healthcare Research in Quality, and as a result have become the second most common reason for ...
Apr 10, 2024
0
2
For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the ...
Apr 8, 2024
0
0
In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...
Apr 8, 2024
0
0
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Apr 8, 2024
0
0